Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

BUY
$191.51 - $216.16 $217,938 - $245,990
1,138 Added 1.49%
77,401 $16.4 Million
Q2 2023

Jul 31, 2023

SELL
$187.64 - $206.25 $6.32 Million - $6.95 Million
-33,690 Reduced 30.64%
76,263 $14.7 Million
Q1 2023

Apr 25, 2023

BUY
$127.59 - $203.08 $369,500 - $588,119
2,896 Added 2.71%
109,953 $22.3 Million
Q4 2022

Feb 06, 2023

SELL
$117.37 - $139.17 $274,645 - $325,657
-2,340 Reduced 2.14%
107,057 $13.8 Million
Q3 2022

Nov 04, 2022

BUY
$135.27 - $180.11 $575,844 - $766,728
4,257 Added 4.05%
109,397 $15 Million
Q2 2022

Jul 29, 2022

SELL
$108.81 - $179.33 $3.58 Million - $5.9 Million
-32,887 Reduced 23.83%
105,140 $18.6 Million
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $219,723 - $289,970
1,837 Added 1.35%
138,027 $19.9 Million
Q4 2021

Feb 09, 2022

BUY
$142.57 - $190.86 $341,312 - $456,918
2,394 Added 1.79%
136,190 $21.6 Million
Q3 2021

Nov 02, 2021

BUY
$142.45 - $169.82 $227,207 - $270,862
1,595 Added 1.21%
133,796 $22.7 Million
Q2 2021

Aug 03, 2021

BUY
$135.08 - $161.1 $7,834 - $9,343
58 Added 0.04%
132,201 $20.9 Million
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $931,355 - $1.29 Million
6,773 Added 5.4%
132,143 $18.3 Million
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $20.6 Million - $26.6 Million
125,370 New
125,370 $23.3 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.